CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

FDA approves Asahi Kasei’s Hovilpri for refractory HSV

FDA Decision

Read the original article

Published by Pharmaceutical Technology on October 12, 2026 10:04 AM

Read Original